Ablative Therapy of Oligometastatic Tumor After Response to Conventional First Line Treatment

NCT07545486 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
1235
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Chirec

Collaborators